BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 21179004)

  • 21. Building multifunctionality into a complex containing master regulators of hematopoiesis.
    Fujiwara T; Lee HY; Sanalkumar R; Bresnick EH
    Proc Natl Acad Sci U S A; 2010 Nov; 107(47):20429-34. PubMed ID: 21059912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SCL/TAL1 in Hematopoiesis and Cellular Reprogramming.
    Hoang T; Lambert JA; Martin R
    Curr Top Dev Biol; 2016; 118():163-204. PubMed ID: 27137657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Divergent functions of hematopoietic transcription factors in lineage priming and differentiation during erythro-megakaryopoiesis.
    Pimkin M; Kossenkov AV; Mishra T; Morrissey CS; Wu W; Keller CA; Blobel GA; Lee D; Beer MA; Hardison RC; Weiss MJ
    Genome Res; 2014 Dec; 24(12):1932-44. PubMed ID: 25319996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic recruitment of Ets1 to both nucleosome-occupied and -depleted enhancer regions mediates a transcriptional program switch during early T-cell differentiation.
    Cauchy P; Maqbool MA; Zacarias-Cabeza J; Vanhille L; Koch F; Fenouil R; Gut M; Gut I; Santana MA; Griffon A; Imbert J; Moraes-Cabé C; Bories JC; Ferrier P; Spicuglia S; Andrau JC
    Nucleic Acids Res; 2016 May; 44(8):3567-85. PubMed ID: 26673693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The paralogous hematopoietic regulators Lyl1 and Scl are coregulated by Ets and GATA factors, but Lyl1 cannot rescue the early Scl-/- phenotype.
    Chan WY; Follows GA; Lacaud G; Pimanda JE; Landry JR; Kinston S; Knezevic K; Piltz S; Donaldson IJ; Gambardella L; Sablitzky F; Green AR; Kouskoff V; Göttgens B
    Blood; 2007 Mar; 109(5):1908-16. PubMed ID: 17053063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequence determinants of DNA binding by the hematopoietic helix-loop-helix transcription factor TAL1: importance of sequences flanking the E-box core.
    Gould KA; Bresnick EH
    Gene Expr; 1998; 7(2):87-101. PubMed ID: 9699481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The basic helix-loop-helix transcription factor TAL1/SCL inhibits the expression of the p16INK4A and pTalpha genes.
    Hansson A; Manetopoulos C; Jönsson JI; Axelson H
    Biochem Biophys Res Commun; 2003 Dec; 312(4):1073-81. PubMed ID: 14651981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia.
    Sanda T; Lawton LN; Barrasa MI; Fan ZP; Kohlhammer H; Gutierrez A; Ma W; Tatarek J; Ahn Y; Kelliher MA; Jamieson CH; Staudt LM; Young RA; Look AT
    Cancer Cell; 2012 Aug; 22(2):209-21. PubMed ID: 22897851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isoforms of the TAL1 transcription factor have different roles in hematopoiesis and cell growth.
    Sharma A; Mistriel-Zerbib S; Najar RA; Engal E; Bentata M; Taqatqa N; Dahan S; Cohen K; Jaffe-Herman S; Geminder O; Baker M; Nevo Y; Plaschkes I; Kay G; Drier Y; Berger M; Salton M
    PLoS Biol; 2023 Jun; 21(6):e3002175. PubMed ID: 37379322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex.
    El Omari K; Hoosdally SJ; Tuladhar K; Karia D; Vyas P; Patient R; Porcher C; Mancini EJ
    Blood; 2011 Feb; 117(7):2146-56. PubMed ID: 21076045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia.
    Mansour MR; Sanda T; Lawton LN; Li X; Kreslavsky T; Novina CD; Brand M; Gutierrez A; Kelliher MA; Jamieson CH; von Boehmer H; Young RA; Look AT
    J Exp Med; 2013 Jul; 210(8):1545-57. PubMed ID: 23857984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PADI4 acts as a coactivator of Tal1 by counteracting repressive histone arginine methylation.
    Kolodziej S; Kuvardina ON; Oellerich T; Herglotz J; Backert I; Kohrs N; Buscató El; Wittmann SK; Salinas-Riester G; Bonig H; Karas M; Serve H; Proschak E; Lausen J
    Nat Commun; 2014 May; 5():3995. PubMed ID: 24874575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins.
    Hsu HL; Huang L; Tsan JT; Funk W; Wright WE; Hu JS; Kingston RE; Baer R
    Mol Cell Biol; 1994 Feb; 14(2):1256-65. PubMed ID: 8289805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SCL/TAL1: a multifaceted regulator from blood development to disease.
    Porcher C; Chagraoui H; Kristiansen MS
    Blood; 2017 Apr; 129(15):2051-2060. PubMed ID: 28179281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of endoglin overexpression during embryoid body development.
    Baik J; Borges L; Magli A; Thatava T; Perlingeiro RC
    Exp Hematol; 2012 Oct; 40(10):837-46. PubMed ID: 22728030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The transcriptional program controlled by the stem cell leukemia gene Scl/Tal1 during early embryonic hematopoietic development.
    Wilson NK; Miranda-Saavedra D; Kinston S; Bonadies N; Foster SD; Calero-Nieto F; Dawson MA; Donaldson IJ; Dumon S; Frampton J; Janky R; Sun XH; Teichmann SA; Bannister AJ; Göttgens B
    Blood; 2009 May; 113(22):5456-65. PubMed ID: 19346495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired in vitro erythropoiesis following deletion of the Scl (Tal1) +40 enhancer is largely compensated for in vivo despite a significant reduction in expression.
    Ferreira R; Spensberger D; Silber Y; Dimond A; Li J; Green AR; Göttgens B
    Mol Cell Biol; 2013 Mar; 33(6):1254-66. PubMed ID: 23319051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct functions for different scl isoforms in zebrafish primitive and definitive hematopoiesis.
    Qian F; Zhen F; Xu J; Huang M; Li W; Wen Z
    PLoS Biol; 2007 May; 5(5):e132. PubMed ID: 17472439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells.
    Deleuze V; El-Hajj R; Chalhoub E; Dohet C; Pinet V; Couttet P; Mathieu D
    PLoS One; 2012; 7(7):e40484. PubMed ID: 22792348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.
    McCormack MP; Shields BJ; Jackson JT; Nasa C; Shi W; Slater NJ; Tremblay CS; Rabbitts TH; Curtis DJ
    Blood; 2013 Sep; 122(12):2093-103. PubMed ID: 23926305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.